Dr. Nour Z. Suid, MA, PSYD Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 5316 Yacht Haven Grande Ste S104, St Thomas, VI 00802 Phone: 340-513-0418 |
Denise Chamblee Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 9150 Estate Thomas Ste 108, St Thomas, VI 00802 Phone: 678-923-0138 |
Reneta Adjodha Counselor Medicare: Not Enrolled in Medicare Practice Location: 9150 Estate Thomas Ste 108, St Thomas, VI 00802 Phone: 340-473-5146 |
Semone Elizabeth Rey Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 9150 Estate Thomas Ste 108, St Thomas, VI 00802 Phone: 340-473-5146 |
Melinda D Richards, LPC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 1619 Sixth St Unit 3, St Thomas, VI 00802 Phone: 340-513-1234 Fax: 404-521-4527 |
News Archive
Breakfast is the most important meal of the day, yet the alarming reality is that 1 in 4 children live in homes where food is not always available, sometimes making breakfast hard to come by. As a breakfast leader, Kellogg has partnered with Action for Healthy Kids to launch the Share Your Breakfast program to encourage Americans to help children who might otherwise go without.
Hospitals that use a simple strategy of enhancing communication with family members of patients dying in the intensive care unit can greatly reduce post-traumatic stress disorder, anxiety and depression after their loved one dies, according to a study to be presented at the American Thoracic Society International Conference in San Francisco.
Two of the world's leading universities are joining forces to combine neuroscience and engineering in order to alleviate human suffering caused by such neurological disabilities as paralysis and deafness. Scientists, engineers, and clinicians at Harvard Medical School (HMS) and Ecole Polytechnique F-d-rale de Lausanne (EPFL) will collaborate on six pioneering neuroengineering projects made possible thanks to a $3.6 million grant from the Bertarelli Foundation.
Mylan Inc. has announced that its subsidiary, Mylan Pharmaceuticals Inc., received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fluoxetine Capsules USP, 10 mg and 20 mg.
› Verified 6 days ago